Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Montag, Judith ^a   Hitt, Reiner ^b   Opitz, Lennart ^b   Schulz Schaeffer, Walter J ^c   Hunsmann, Gerhard ^a   Motzkus, Dirk ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b Institute for Biochemistry and Molecular Cell Biology   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; BOVINE SPONGIFORM ENCEPHALOPATHY AGENT; BRAIN; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEREGULATION; DISEASE COURSE; EXPERIMENTAL PRION DISEASE; FROZEN SECTION; GENE EXPRESSION; GENE TARGETING; HUMAN; IDIOPATHIC PRION DISEASE; IMMUNE RESPONSE; MACACA; MICROARRAY ANALYSIS; MOUSE; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PILOT STUDY; PRION DISEASE; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCRAPIE;

ANIMALIA; MACACA; MUS;

EID: 70349233931     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-36     Document Type: Article

References (27)

1. Introduction to the transmissible spongiform encephalopathies or prion diseases. B Chesebro, Br Med Bull 2003 66 1 20 10.1093/bmb/66.1.1 14522845
2. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. KM Pan M Baldwin J Nguyen M Gasset A Serban D Groth I Mehlhorn Z Huang RJ Fletterick FE Cohen SB Prusiner, Proc Natl Acad Sci USA 1993 90 10962 10966 10.1073/pnas.90.23.10962 7902575
3. MicroRNAs (miRNAs) in Neurodegenerative Diseases. PT Nelson WX Wang BW Rajeev, Brain Pathol 2008 18 130 138 10.1111/j.1750-3639.2007.00120.x 18226108
4. MicroRNAs in neurodegeneration. N Bushati SM Cohen, Curr Opin Neurobiol 2008 18 292 296 10.1016/j.conb.2008.07.001 18662781
5. microRNA functions. N Bushati SM Cohen, Annu Rev Cell Dev Biol 2007 23 175 205 10.1146/annurev.cellbio.23.090506.123406 17506695
6. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. J Bilen N Liu BG Burnett RN Pittman NM Bonini, Mol Cell 2006 24 157 163 10.1016/j.molcel.2006.07.030 17018300
7. Cerebellar neurodegeneration in the absence of microRNAs. A Schaefer D O'Carroll CL Tan D Hillman M Sugimori R Llinas P Greengard, J Exp Med 2007 204 1553 1558 10.1084/jem.20070823 17606634
8. A MicroRNA feedback circuit in midbrain dopamine neurons. J Kim K Inoue J Ishii WB Vanti SV Voronov E Murchison G Hannon A Abeliovich, Science 2007 317 1220 1224 10.1126/science.1140481 17761882
9. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. AN Packer Y Xing SQ Harper L Jones BL Davidson, J Neurosci 2008 28 14341 14346 10.1523/JNEUROSCI.2390-08.2008 19118166
10. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. V Boissonneault I Plante S Rivest P Provost, J Biol Chem 2009 284 1971 1981 10.1074/jbc.M807530200 18986979
11. A miRNA signature of prion induced neurodegeneration. R Saba CD Goodman RL Huzarewich C Robertson SA Booth, PLoS ONE 2008 3 3652 10.1371/journal.pone. 0003652 18987751
12. Risk of oral infection with bovine spongiform encephalopathy agent in primates. CI Lasmezas E Comoy S Hawkins C Herzog F Mouthon T Konold F Auvre E Correia N Lescoutra-Etchegaray N Sales G Wells P Brown JP Deslys, Lancet 2005 365 781 783 15733719
13. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. WJ Schulz-Schaeffer S Tschoke N Kranefuss W Drose D Hause-Reitner A Giese MH Groschup HA Kretzschmar, Am J Pathol 2000 156 51 56 10623653
14. An optimized isolation and labeling platform for accurate microRNA expression profiling. J Shingara K Keiger J Shelton W Laosinchai-Wolf P Powers R Conrad D Brown E Labourier, Rna 2005 11 1461 1470 10.1261/rna.2610405 16043497
15. Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling. J Landgrebe G Welzl T Metz MM van Gaalen H Ropers W Wurst F Holsboer, J Psychiatr Res 2002 36 119 129 10.1016/S0022- 3956(01)00061-9 11886689
16. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. S Baskerville DP Bartel, Rna 2005 11 241 247 10.1261/rna.7240905 15701730
17. A mammalian microRNA expression atlas based on small RNA library sequencing. P Landgraf M Rusu R Sheridan A Sewer N Iovino A Aravin S Pfeffer A Rice AO Kamphorst M Landthaler C Lin ND Socci L Hermida V Fulci S Chiaretti R Foa J Schliwka U Fuchs A Novosel RU Muller B Schermer U Bissels J Inman Q Phan M Chien DB Weir R Choksi G De Vita D Frezzetti HI Trompeter V Hornung G Teng G Hartmann M Palkovits R Di Lauro P Wernet G Macino CE Rogler JW Nagle J Ju FN Papavasiliou T Benzing P Lichter W Tam MJ Brownstein A Bosio A Borkhardt JJ Russo C Sander M Zavolan T Tuschl, Cell 2007 129 1401 1414 10.1016/j.cell.2007. 04.040 17604727
18. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. EJ Lee M Baek Y Gusev DJ Brackett GJ Nuovo TD Schmittgen, Rna 2008 14 35 42 10.1261/rna.804508 18025253
19. A novel method to monitor the expression of microRNAs. HJ Fu J Zhu M Yang ZY Zhang Y Tie H Jiang ZX Sun XF Zheng, Mol Biotechnol 2006 32 197 204 10.1385/MB:32:3:197 16632886
20. Prediction of mammalian microRNA targets. BP Lewis IH Shih MW Jones-Rhoades DP Bartel CB Burge, Cell 2003 115 787 798 10.1016/S0092-8674(03) 01018-3 14697198
21. MicroRNA alterations in head and neck squamous cell carcinoma. SS Chang WW Jiang I Smith LM Poeta S Begum C Glazer S Shan W Westra D Sidransky JA Califano, Int J Cancer 2008 123 2791 2797 10.1002/ijc.23831 18798260
22. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. JJ Zhao J Yang J Lin N Yao Y Zhu J Zheng J Xu JQ Cheng JY Lin X Ma, Childs Nerv Syst 2009 25 13 20 10.1007/s00381-008-0701-x 18818933
23. microRNA expression in the biology, prognosis, and therapy of Waldenstrom macroglobulinemia. AM Roccaro A Sacco C Chen J Runnels X Leleu F Azab AK Azab X Jia HT Ngo MR Melhem N Burwick L Varticovski CD Novina BJ Rollins KC Anderson IM Ghobrial, Blood 2009 113 4391 4402 10.1182/blood-2008-09-178228 19074725
24. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. XH Wang RZ Qian W Zhang SF Chen HM Jin RM Hu, Clin Exp Pharmacol Physiol 2009 36 181 188 10.1111/j.1440-1681.2008.05057.x 18986336
25. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. G Schoch H Seeger J Bogousslavsky M Tolnay RC Janzer A Aguzzi M Glatzel, PLoS Med 2006 3 14 10.1371/journal.pmed.0030014 16354106
26. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. WX Wang BW Rajeev AJ Stromberg N Ren G Tang Q Huang I Rigoutsos PT Nelson, J Neurosci 2008 28 1213 1223 10.1523/JNEUROSCI.5065-07.2008 18234899
27. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. J Winer CK Jung I Shackel PM Williams, Anal Biochem 1999 270 41 49 10.1006/abio.1999.4085 10328763